Preimplantation Genetic Testing Market, By Product (PGT-A Testing Services, PGT-M Testing Services, and PGT-SR Testing Services), By Application, By End User, By Technology, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV1789
|
Published Date
July 2026
|
Pages
399
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Preimplantation Genetic Testing Market size was valued at US$ 830.4 Million in 2025, expanding at a CAGR of 9.8% from 2026 to 2033.
The Preimplantation Genetic Testing (PGT) Market involves advanced genetic screening technologies used to evaluate embryos created through in vitro fertilization (IVF) before implantation. These tests help identify chromosomal abnormalities, inherited genetic disorders, and structural chromosome alterations, enabling the selection of embryos with a higher likelihood of healthy development. By improving embryo selection, PGT enhances IVF success rates, reduces the risk of transmitting genetic conditions, and helps lower the chances of pregnancy loss associated with genetic abnormalities.
The market is witnessing significant growth due to the increasing prevalence of genetic disorders, rising infertility rates, delayed parenthood among women, and the growing adoption of assisted reproductive technology (ART) procedures worldwide. Technological advancements in next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray-based testing are improving the accuracy, reliability, and efficiency of embryo genetic screening. Additionally, increasing awareness regarding reproductive genetics, supportive government initiatives for fertility care, and rising investments in precision medicine and genomic technologies are expected to further accelerate the expansion of the global Preimplantation Genetic Testing Market during the forecast period.
Preimplantation Genetic Testing Market- Market Dynamics
Growing Adoption of Assisted Reproductive Technologies Driving Preimplantation Genetic Testing Market Growth
The increasing adoption of assisted reproductive technology (ART) is a major factor driving the growth of the Preimplantation Genetic Testing (PGT) Market. Rising infertility rates due to delayed parenthood, changing lifestyle patterns, obesity, and reproductive health disorders are encouraging more couples to pursue fertility treatments, particularly in vitro fertilization (IVF). PGT has become an essential component of IVF procedures as it enables the identification of chromosomal abnormalities, single-gene disorders, and structural genetic variations before embryo implantation. By supporting the selection of genetically healthy embryos, PGT improves IVF success rates, enhances implantation outcomes, reduces the likelihood of miscarriage, and minimizes the risk of passing inherited disorders to future generations.
According to the European Society of Human Reproduction and Embryology (ESHRE), more than 1 million ART treatment cycles are performed annually in Europe, reflecting the increasing acceptance of fertility treatments and the growing demand for advanced embryo screening solutions. Furthermore, advancements in next-generation sequencing (NGS), polymerase chain reaction (PCR), and other genomic technologies have improved the accuracy, efficiency, and accessibility of PGT procedures. Growing awareness of reproductive genetics, expansion of fertility clinics, supportive healthcare policies, and increasing demand for personalized reproductive care are further accelerating market adoption. The continued rise in IVF procedures and the growing preference for precision-based fertility solutions are expected to significantly support the expansion of the Preimplantation Genetic Testing Market during the forecast period.
Preimplantation Genetic Testing Market- Segmentation Analysis:
The Global Preimplantation Genetic Testing Market is segmented on the basis of Product, Application, End User, Technology, and Region.
Based on Test Type, Preimplantation Genetic Testing for Aneuploidy (PGT-A) holds the largest share of the Preimplantation Genetic Testing Market due to its widespread application in IVF procedures for identifying chromosomal abnormalities in embryos before implantation. PGT-A helps fertility specialists select embryos with a normal chromosome number, improving implantation potential, reducing miscarriage risks, and increasing the probability of successful pregnancies, particularly among women of advanced maternal age. The growing adoption of next-generation sequencing (NGS) technologies has further improved the accuracy, speed, and reliability of PGT-A testing. For instance, in May 2026, GenEmbryomics Limited introduced XGEN PGT-X™, a clinical-grade whole-genome preimplantation genetic testing solution designed for IVF embryos, enabling comprehensive embryo genomic analysis through advanced sequencing capabilities. Additionally, Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is expected to witness significant growth due to increasing demand for screening inherited single-gene disorders before embryo transfer. According to the World Health Organization (WHO), millions of people worldwide are affected by genetic disorders, increasing the importance of early genetic screening and reproductive health solutions.
Based on Application, IVF Embryo Selection represents the leading segment due to the increasing number of IVF procedures globally and the rising focus on improving fertility treatment outcomes. PGT enables clinicians to evaluate embryo quality from a genetic perspective, supporting informed embryo selection and increasing the likelihood of successful implantation. Other applications, including genetic disorder screening, prevention of recurrent pregnancy loss, and advanced fertility planning, are also gaining adoption as reproductive genetics becomes an increasingly important part of fertility care. According to the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), millions of assisted reproductive technology cycles are performed globally each year, reflecting the growing demand for advanced fertility procedures and genetic screening solutions.
Based on End User, Fertility Clinics account for the largest market share due to the availability of specialized IVF laboratories, embryo biopsy facilities, reproductive specialists, and integrated genetic testing services. These clinics are increasingly adopting PGT technologies to provide personalized fertility solutions and improve treatment success rates for patients undergoing assisted reproduction. The expansion of fertility centers and increasing investments in reproductive healthcare infrastructure are further supporting market growth. According to the United Nations Population Fund (UNFPA), infertility affects a significant proportion of the global population, highlighting the growing need for accessible and advanced fertility care services, including genetic testing solutions.
Based on Technology, Next-Generation Sequencing (NGS) dominates the Preimplantation Genetic Testing Market due to its high accuracy, scalability, and ability to analyze multiple genetic abnormalities simultaneously. NGS has become the preferred technology for modern PGT procedures because it enables comprehensive chromosomal screening and detection of genetic mutations with improved efficiency compared with conventional testing methods. Continuous advancements in genomic technologies, declining sequencing costs, and increasing adoption of precision medicine approaches are further accelerating the use of NGS in reproductive genetics. According to the National Human Genome Research Institute (NHGRI), advancements in genomic sequencing technologies have significantly expanded the application of genetic testing in healthcare, supporting the wider adoption of precision-based diagnostic solutions such as PGT.
Preimplantation Genetic Testing Market- Geographical Insights
North America holds the largest share of the Preimplantation Genetic Testing (PGT) Market due to the widespread adoption of assisted reproductive technologies (ART), availability of advanced genetic testing infrastructure, and the presence of well-established fertility clinics and reproductive genetics laboratories. The region’s market growth is further supported by increasing awareness of genetic disorders, rising maternal age, growing demand for IVF procedures, and the expanding use of next-generation sequencing (NGS)-based embryo screening technologies. According to the Centers for Disease Control and Prevention (CDC), the United States continues to perform a significant number of ART procedures annually, driven by increasing demand for fertility treatments. The CDC’s National ART Surveillance System (NASS) collects data from approximately 500 fertility clinics across the country and reported around 435,426 ART cycles in 2022. The growing number of ART procedures has increased the integration of PGT into IVF workflows, strengthening North America’s leading position in the global market.
Europe represents another significant region in the Preimplantation Genetic Testing Market, supported by established fertility care networks, favorable regulatory frameworks, and continuous advancements in reproductive genetic technologies. Countries such as Spain, the United Kingdom, Italy, and Denmark have witnessed increasing adoption of IVF procedures and embryo screening services due to rising infertility concerns and growing awareness of genetic testing benefits. According to the European Society of Human Reproduction and Embryology (ESHRE), more than 1 million ART treatment cycles are performed annually across Europe, demonstrating strong demand for advanced fertility solutions, including PGT-A, PGT-M, and PGT-SR testing. Furthermore, the increasing adoption of NGS-based screening methods in fertility clinics, combined with ongoing investments in reproductive healthcare infrastructure, is expected to further accelerate the growth of the PGT market across the European region.
Preimplantation Genetic Testing Market- Competitive Landscape:
The competitive landscape of the Preimplantation Genetic Testing (PGT) Market is characterized by the presence of specialized reproductive genetics laboratories, molecular diagnostics companies, and assisted reproductive technology (ART) solution providers that compete through technological innovation, laboratory expansion, strategic partnerships, and development of advanced genetic testing platforms. Key players operating in the market include Vitrolife Group (Igenomix), CooperGenomics, Thermo Fisher Scientific Inc., Illumina, Inc., Natera, Inc., Fulgent Genetics, Genea Biomedx, Invitae Corporation, Eurofins Scientific, and Laboratory Corporation of America Holdings (Labcorp). These companies are focusing on the development of advanced next-generation sequencing (NGS)-based PGT solutions, automated laboratory workflows, and expanded testing capabilities to improve the accuracy, efficiency, and turnaround time of embryo genetic screening. Market participants are increasingly investing in the expansion of global laboratory networks, collaborations with fertility clinics, and integration of genomic technologies into IVF procedures to strengthen their market presence. The growing demand for personalized reproductive healthcare and advanced embryo screening solutions is encouraging companies to enhance their product portfolios and adopt innovative approaches, thereby intensifying competition in the global Preimplantation Genetic Testing Market.
Recent Developments:
- In April 2024, GenEmbryomics Limited and Progenesis Inc. entered into a strategic partnership aimed at improving access to advanced preimplantation genetic testing solutions for IVF patients. The collaboration combined Progenesis’ laboratory expertise with GenEmbryomics’ Panacea-GenomeScreen™ PGT-WGS technology to enable comprehensive whole-genome embryo screening and support the advancement of genetic testing capabilities in reproductive medicine.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Vitrolife Group (Igenomix)
- CooperGenomics (CooperSurgical)
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Labcorp)
- Eurofins Scientific
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
- Revvity, Inc.
- BGI Genomics Co., Ltd.
- Genea Biomedx
- GeneDx
- SOPHiA GENETICS
- FUJIFILM Irvine Scientific
- Oxford Gene Technology (Sysmex)
- Pacific Biosciences (PacBio)
- Merck KGaA
- Juno Genetics
- Progenesis, Inc.
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- PGT-A Testing Services
- PGT-M Testing Services
- PGT-SR Testing Services
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- IVF Embryo Selection
- Genetic Disorder Screening
- Recurrent Pregnancy Loss Prevention
- Advanced Fertility Planning
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Fertility Clinics
- Hospitals
- Diagnostic Laboratories
- Research Institutes
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Microarray Technology
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Preimplantation Genetic Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Preimplantation Genetic Testing Market Snippet by Product
2.1.2. Preimplantation Genetic Testing Market Snippet by Application
2.1.3. Preimplantation Genetic Testing Market Snippet by End-User
2.1.4. Preimplantation Genetic Testing Market Snippet by Country
2.1.5. Preimplantation Genetic Testing Market Snippet by Region
2.2. Competitive Insights
3. Preimplantation Genetic Testing Key Market Trends
3.1. Preimplantation Genetic Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Preimplantation Genetic Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Preimplantation Genetic Testing Market Opportunities
3.4. Preimplantation Genetic Testing Market Future Trends
4. Preimplantation Genetic Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Preimplantation Genetic Testing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Preimplantation Genetic Testing Market Landscape
6.1. Preimplantation Genetic Testing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Preimplantation Genetic Testing Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
7.1.2. Reagents & consumables
7.1.3. Instruments
7.1.4. Software
8. Preimplantation Genetic Testing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Chromosomal Abnormalities
8.1.3. X-linked diseases
8.1.4. Embryo testing
8.1.5. Aneuploidy screening
8.1.6. HLA typing
8.1.7. Others
9. Preimplantation Genetic Testing Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
9.1.2. Hospitals
9.1.3. Diagnostic centers
9.1.4. Fertility centers
9.1.5. Others
10. Preimplantation Genetic Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Preimplantation Genetic Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Preimplantation Genetic Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Preimplantation Genetic Testing Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Preimplantation Genetic Testing Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Preimplantation Genetic Testing Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Preimplantation Genetic Testing Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. GenEmbryomics
11.2.2. Quest Diagnostics Incorporated
11.2.3. Natera, Inc.
11.2.4. COOPER SURGICAL, INC.
11.2.5. Genea Pty Limited
11.2.6. Invitae Corporation
11.2.7. Laboratory Corporation of America Holdings
11.2.8. Thermo Fisher Scientific Inc.
11.2.9. Bioarray S.L.
11.2.10. Illumina, Inc.
11.2.11. Igenomix
11.2.12. RGI
11.2.13. F. Hoffmann-La Roche Ltd
11.2.14. Prelude Network
11.2.15. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Vitrolife Group (Igenomix)
- CooperGenomics (CooperSurgical)
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Labcorp)
- Eurofins Scientific
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
- Revvity, Inc.
- BGI Genomics Co., Ltd.
- Genea Biomedx
- GeneDx
- SOPHiA GENETICS
- FUJIFILM Irvine Scientific
- Oxford Gene Technology (Sysmex)
- Pacific Biosciences (PacBio)
- Merck KGaA
- Juno Genetics
- Progenesis, Inc.
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- PGT-A Testing Services
- PGT-M Testing Services
- PGT-SR Testing Services
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- IVF Embryo Selection
- Genetic Disorder Screening
- Recurrent Pregnancy Loss Prevention
- Advanced Fertility Planning
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Fertility Clinics
- Hospitals
- Diagnostic Laboratories
- Research Institutes
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Microarray Technology
- Others
GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
